Andrew Long Biography and Net Worth

Andy was appointed Executive Vice President & Chief Financial Officer of Owens & Minor, effective November 11, 2019. Previously, served as CEO of Insys Therapeutics, Inc. Before serving as CEO, Andy was the company’s CFO for two years. Prior to joining Insys Therapeutics, Andy spent two years as SVP of Global Finance for Patheon, a $2 billion private equity-backed provider of contract manufacturing services to the bio-pharma industry. He also served as VP of Global Finance for Thermo Fisher Scientific’s Customer Channels Group. Long holds a Master’s of Business Administration degree in finance, marketing, international business and operations management from the Kellogg Graduate School of Business at Northwestern University and a Bachelor of Science in finance from Indiana University.

How old is Andrew G. Long?: Mr. Long is currently 59 years old. There are 7 older executives and no younger executives at Owens & Minor. The oldest executive at Owens & Minor is Mr. Perry A. Bernocchi, Executive VP & CEO of Patient Direct Segment, who is 65 years old. Learn More on Andrew G. Long's age.
How do I contact Andrew G. Long?: The corporate mailing address for Mr. Long and other Owens & Minor executives is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. Owens & Minor can also be reached via phone at (804) 723-7000 and via email at [email protected]. Learn More on Andrew G. Long's contact information.
Has Andrew G. Long been buying or selling shares of Owens & Minor?: Andrew G. Long has not been actively trading shares of Owens & Minor during the last ninety days. Learn More on Andrew G. Long's trading history.
Who are Owens & Minor's active insiders?: Owens & Minor's insider roster includes Robert Henkel (Director), Jeffrey Jochims (COO), Jonathan Leon (SVP), Andrew Long (CFO), Michael Lowry (SVP), Shana Neal (Insider), Nicholas Pace (EVP), and Edward Pesicka (CEO). Learn More on Owens & Minor's active insiders.
Are insiders buying or selling shares of Owens & Minor?: During the last year, insiders at the sold shares 12 times. They sold a total of 356,605 shares worth more than $7,348,853.00. The most recent insider tranaction occured on April, 22nd when SVP Jonathan A Leon sold 5,000 shares worth more than $124,200.00. Insiders at Owens & Minor own 3.6% of the company. Learn More about insider trades at Owens & Minor.
Information on this page was last updated on 4/22/2024.

Andrew G. Long Insider Trading History at Owens & Minor

Andrew G. Long Buying and Selling Activity at Owens & Minor

Owens & Minor Company Overview

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.

Today's Range

Now: $24.12

$23.65

$24.45

50 Day Range

MA: $25.16

$21.18

$27.95

2 Week Range

Now: $24.12

$13.34

$28.35

Volume

486,666 shs

Average Volume

426,466 shs

Market Capitalization

$1.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.43

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…